[1]
|
Lavin M F.ATM:the product of the gene mutated in ataxia-telangiectasia[J].Int J Biochem Cell Biol,1999,31(7):735-740. |
[2]
|
Gang C,Eva Y,Lee HP.The product of the ATM Gene is a 370 kda Nuclear Phosphoprotein[J].J Biol Chem,1996,271:33693-33697. |
[3]
|
Crawford TO.Ataxia telangiectasia[J].Semin Pediatr Neurol,1998,5(4):287-294. |
[4]
|
Keegan KS,Holtzman DA,Plug AW,et al.The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes[J].Genes Dev,1996,10(19):2423-2437. |
[5]
|
International Commission on Radiological Protection.Genetic susceptibility to cancer[J].Ann ICRP,1998;28(1-2):1-157. |
[6]
|
Karin M and Hunter T.Transcriptional control by protein phosphorylation:signal transmission from the cell surface to the nucleus[J].Curr Biol,1995,5(7):747-757. |
[7]
|
Canman CE,Wolff AC,Chen CY,et al.The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia[J].Cancer Res,1994,54 (19):5054-5058. |
[8]
|
Khanna KK,Beamish H,Yan J,et al.Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia[J].Oncogene,1995,11(4):609-618. |
[9]
|
Khanna KK,Keating KE,Kozlov S,et al.ATM associates with and phosphorylates p53:mapping the region of interaction[J].Nat Genet,1998,20(4):398-400. |
[10]
|
BarlowC,Brown KD,Deng CX,et al.Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways[J].Nat Genet,1997,17(4):453-456. |
[11]
|
Kohli M,Jorgensen TJ.The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses[J].Biochem Biophys Res Commun,1999,257(1):168-176. |
[12]
|
Beamish H,Williams R,Chen P,et al.Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation[J].J Biol Chem,1996,271 (34):20486-20493. |
[13]
|
Painter RB,Young BR.Radiosensitivity in ataxia-telangiectasia:a new explanation[J].Proc Natl Acad Sci USA,1980,77(12):7315-7317. |
[14]
|
Zhang N,Chen P,Gatei M,et al.An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells[J].Oncogene,1998,17(7):811-818. |
[15]
|
de Murcia G,Menissier de Murcia J.Poly (ADP-ribose) polymerase:a molecular nick-sensor[J].Trends Biochem Sci,1994,19(4):172-176. |
[16]
|
Paules RS,Levedakou EN,Wilson-SJ,et al.Defective G2 checkpoint function in cells from individuals with familial cancer syndromes[J].Cancer Res,1995,55(8):1763-1773. |
[17]
|
Kyriakis JM,Avruch J.Sounding the alarm:protein kinase cascades activated by stress and inflammation[J].J Biol Chem,1996,271(40):24313-24316. |
[18]
|
Kharbanda S,Ren R,Pandey P,et al.Activation of the c-Ab1 tyrosine kinase in the stress response to DNA-damaging agents[J].Nature,1995,376(6543):785-788. |
[19]
|
Shafman T,Khanna KK,Kedar P,et al.Interaction between ATM protein and c-Ab1 in response to DNA damage[J].Nature,1997,387(6632):520-523. |
[20]
|
Baskaran R,Wood LD,Whitaker LL,et al.Ataxia telangiectasia mutant protein activates c-Ab1 tyrosine kinase in response to ionizing radiation[J].Nature,1997,387(6632):516-519. |
[21]
|
Pendergast AM.Nuclear tyrosine kinases:from Ab1 to WEE1[J].Curr Opin Cell Biol,1996,174-181. |
[22]
|
Sen CK,Packer L.Antioxidant and redox regulation of gene transcription[J].J FASEB,1996,10(7):709-720. |
[23]
|
Baldwin AS Jr.The NF-kappa B and I kappa B proteins:new discoveries and insights[J].Annu Rev Immunol,1996,14:649-683. |
[24]
|
KaltschmidtB,Baeuerle PA,Kaltschmidt C.Potential involvement of the transcription factor NF-kappa B in neurological disorders[J].Mol Aspects Med,1993,14(3):171-190. |
[25]
|
Harper JW,Elledge SJ.Cdk inhibitors in development and cancer[J].Curr Opin Genet Dev,1996,6(1):56-64. |
[26]
|
Xu Y,Ashley T,Brainerd EE,et al.Targeted disruption of ATM leads to growth retardation,chromosomal fragmentation during meiosis,immune defects,and thymic lymphoma[J].Genes Dev,1996,10(19):2411-2422. |
[27]
|
Jaffrey SR,Snyder SH.Nitric oxide:a neural messenger[J].Ann Rev Cell Dev Biol,1995,11:417-440. |
[28]
|
Stadtman ER.Protein oxidation and aging[J].Science,1992,257(5074):1220-1224. |